QUANTINOVA
LIVE

Serial Number

79144043

Owner

Qiagen GmbH

Attorney

Victoria Friedman

Filing Date

Oct 16, 2013

Add to watchlist:

No watchlists yet
View on USPTO

QUANTINOVA Trademark

Serial Number: 79144043 • Registration: 4603851

QUANTINOVA is a trademark filed by Qiagen GmbH on October 16, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Qiagen GmbH

Qiagen Str. 1
Hilden 40724 , DE

Entity Type: 99

Trademark Details

Filing Date

October 16, 2013

Registration Date

September 16, 2014

Published for Opposition

July 1, 2014

Goods & Services

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for scientific and research use in the nature of sample preparation and for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industrial and scientific purposes, kits comprising reagents and solvents for scientific research use for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids, namely, kits comprising polymerase chain reaction (PCR) reagents for industrial and scientific research purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; kits comprising chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; kits comprising chemical reagents for conversion of RNA into cDNA for scientific research purposes

[Diagnostic reagents for medical and veterinary medical purposes, medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes, kits comprising medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; kits comprising reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 14, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 19, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 19, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 19, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 18, 2025 APRE
TEAS SECTION 71 RECEIVED
Aug 30, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 16, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Aug 31, 2023 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 3, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 20, 2021 INPS
INVALIDATION PROCESSED
Sep 20, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 5, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jan 5, 2021 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jan 5, 2021 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 7, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 21, 2020 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 13, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 24, 2015 FICS
FINAL DISPOSITION PROCESSED
Feb 24, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 16, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2014 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 22, 2014 NREP
PUBLISHED FOR OPPOSITION
Jul 1, 2014 PUBO
NOTICE OF PUBLICATION
Jun 11, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 27, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2014 CRFA
ASSIGNED TO LIE
May 14, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2014 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2014 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 29, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 25, 2014 MAFR
ASSIGNED TO EXAMINER
Mar 21, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 20, 2014 REPR